Context Therapeutics Inc.
CNTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001842952
No open-market purchases or sales by Context Therapeutics Inc. insiders were filed in the last 90 days; 79 institutions reported holding it in 13F filings for Q2 2026, worth $34.8M in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Context Therapeutics Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 37
- −1 vs. Q2 2025
- Shares held
- 69.0M
- +361.7K (+0.5%) vs. Q2 2025
- Total value
- $66.8M
- +$21.9M (+48.6%) vs. Q2 2025
- New holders
- 6
- 6 more added
- Sold out
- 7
- 7 more reduced
1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CNTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 79 | $34.8M |
| Q1 2026 | 60 | $194.6M |
| Q4 2025 | 43 | $96.0M |
| Q3 2025 | 37 | $66.8M |
| Q2 2025 | 39 | $45.0M |
| Q1 2025 | 42 | $43.7M |
| Q4 2024 | 52 | $76.4M |
| Q3 2024 | 42 | $111.2M |
| Q2 2024 | 34 | $114.3M |
| Q1 2024 | 25 | $5.43M |
| Q4 2023 | 24 | $4.02M |
| Q3 2023 | 23 | $3.89M |
| Q2 2023 | 22 | $3.58M |
| Q1 2023 | 22 | $722.6K |
| Q4 2022 | 24 | $2.55M |
| Q3 2022 | 24 | $4.59M |
| Q2 2022 | 20 | $6.32M |
| Q1 2022 | 16 | $6.30M |
| Q4 2021 | 19 | $9.44M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Context Therapeutics Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| MPM Oncology Impact Management LP | 14,705,882 | $14.2M | 2.33% | 00.0% | Unchanged |
| Avidity Partners Management LP | 8,981,855 | $8.70M | 1.98% | +1,504,600+20.1% | Added |
| Nextech Invest, Ltd. | 7,419,355 | $7.19M | 1.09% | 00.0% | Unchanged |
| Deep Track Capital, LP | 7,419,355 | $7.19M | 0.20% | 00.0% | Unchanged |
| Blue Owl Capital Holdings LP | 7,407,906 | $7.18M | 2.23% | 00.0% | Unchanged |
| Great Point Partners LLC | 4,683,711 | $4.54M | 1.89% | 00.0% | Unchanged |
| Franklin Resources Inc | 4,003,380 | $3.88M | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 3,495,031 | $3.39M | 0.00% | +134,449+4.0% | Added |
| Blackstone Group Inc. | 2,440,330 | $2.36M | 0.01% | 00.0% | Unchanged |
| Alyeska Investment Group, L.P. | 1,663,355 | $1.61M | 0.00% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 1,661,950 | $1.61M | 0.10% | −273,534−14.1% | Reduced |
| Sio Capital Management, LLC | 1,341,636 | $1.30M | 0.33% | 00.0% | Unchanged |
| BlackRock, Inc. | 848,970 | $822.5K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 608,577 | $589.9K | 0.00% | −29,233−4.6% | Reduced |
| Affinity Asset Advisors, LLC | 402,653 | $390.1K | 0.04% | −115,372−22.3% | Reduced |
| ADAR1 Capital Management, LLC | 351,094 | $340.1K | 0.03% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 320,127 | $310.1K | 0.00% | −43,803−12.0% | Reduced |
| State Street Corp | 152,607 | $147.8K | 0.00% | 00.0% | Unchanged |
| Walleye Capital LLC | 132,786 | $128.6K | 0.00% | 00.0% | Unchanged |
| HighTower Advisors, LLC | 125,852 | $121.9K | 0.00% | 00.0% | Unchanged |
| Pathstone Holdings, LLC | 110,244 | $106.8K | 0.00% | +110,244 | New |
| Mill Creek Capital Advisors, LLC | 104,631 | $101.4K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 103,363 | $100.1K | 0.00% | +103,363 | New |
| Velan Capital Investment Management LP | 100,000 | $96.9K | 0.09% | 00.0% | Unchanged |
| Clear Harbor Asset Management, LLC | 92,804 | $89.9K | 0.01% | +35,000+60.5% | Added |
| Qube Research & Technologies Ltd | 82,111 | $79.5K | 0.00% | −24,668−23.1% | Reduced |
| Northern Trust Corp | 66,384 | $64.3K | 0.00% | −47,181−41.5% | Reduced |
| Marshall Wace, LLP | 35,750 | $34.7K | 0.00% | +35,750 | New |
| Advisor Group Holdings, Inc. | 25,500 | $24.6K | 0.00% | +15,000+142.9% | Added |
| Susquehanna International Group, LLP | 21,967 | $21.3K | 0.00% | +21,967 | New |
| Cerity Partners LLC | 20,000 | $19.4K | 0.00% | 00.0% | Unchanged |
| Caxton Corp | 18,403 | $17.8K | 0.08% | 00.0% | Unchanged |
| XTX Topco Ltd | 10,597 | $10.3K | 0.00% | +10,597 | New |
| UBS Group AG | 7,382 | $7.15K | 0.00% | +7,012+1,895.1% | Added |
| Bank of America Corp | 434 | $420 | 0.00% | −109−20.1% | Reduced |
| Barclays PLC | 167 | $162 | 0.00% | +167 | New |
| SBI Securities Co., Ltd. | 117 | $113 | 0.00% | +4+3.5% | Added |
| Woodline Partners LP | 0 | $0 | 0.00% | −680,188−100.0% | Sold out |
| Luminus Management LLC | 0 | $0 | 0.00% | −328,222−100.0% | Sold out |
| GTS Securities LLC | 0 | $0 | 0.00% | −44,176−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −17,067−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −7,414−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −3,500−100.0% | Sold out |
| Newbridge Financial Services Group, Inc. | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Congress Wealth Management LLC | – | – | – | – | Not filed |